Cargando…

Letter to the editor: Korean clinical practice guideline for benign prostatic hyperplasia

Detalles Bibliográficos
Autores principales:	Jung, Jae Hung, Dahm, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2016
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949698/ https://www.ncbi.nlm.nih.gov/pubmed/27437541 http://dx.doi.org/10.4111/icu.2016.57.4.303

Ejemplares similares

The authors reply: Korean clinical practice guideline for benign prostatic hyperplasia
por: Yeo, Jeong Kyun, et al.
Publicado: (2016)

Korean clinical practice guideline for benign prostatic hyperplasia
por: Yeo, Jeong Kyun, et al.
Publicado: (2016)

Letter to the editor: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia
por: Kadihasanoglu, Mustafa, et al.
Publicado: (2015)

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition)
por: Zeng, Xian-Tao, et al.
Publicado: (2022)

Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia
por: Dahm, Philipp, et al.
Publicado: (2021)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia
por: Rahman, Fakhri, et al.
Publicado: (2019)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Transurethral Microwave Thermotherapy for Benign Prostatic Hyperplasia: An Updated Cochrane Review
por: Franco, Juan Victor Ariel, et al.
Publicado: (2022)

Letter to the Editor: Commentary on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
por: Tae, Bum Sik, et al.
Publicado: (2017)

Patterns in the Diagnosis and Management of Benign Prostatic Hyperplasia in a Country that does not have Country-Specific Clinical Practice Guidelines
por: Paick, Jae-Seung, et al.
Publicado: (2007)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia - reply to the letter from Cohen, Peehl and Rosenfeld
por: Mantzoros, CS, et al.
Publicado: (1998)

Clinical Effects of Discontinuing 5-Alpha Reductase Inhibitor in Patients With Benign Prostatic Hyperplasia
por: Kim, Won, et al.
Publicado: (2014)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

The Urological Society of India guidelines on management of benign prostatic hyperplasia/benign prostatic obstruction (Executive summary)
por: Sabnis, Ravindra Bhalchandra, et al.
Publicado: (2021)

Benign Prostatic Hyperplasia
Publicado: (2015)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
por: Cohen, P., et al.
Publicado: (1998)

Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures
por: Franco, Juan V.A., et al.
Publicado: (2023)

Letter to the Editor [Letter]
por: Félix, Sylvie
Publicado: (2021)

Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
por: Coenen, Heinz H., et al.
Publicado: (2018)

Open letter to journal editors on: International Consensus Radiochemistry Nomenclature Guidelines
por: Coenen, Heinz H., et al.
Publicado: (2019)

Korean Urologist's View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey
por: Oh, Cheol Young, et al.
Publicado: (2010)

Author Response to Letter to the Editor
por: Ha, Jongmok, et al.
Publicado: (2019)

Inflammatory response to Trichomonas vaginalis in the pathogenesis of prostatitis and benign prostatic hyperplasia
por: Han, Ik-Hwan, et al.
Publicado: (2023)

Is Serenoa repens Effective in the Treatment of Benign Prostatic Hyperplasia?
por: Çeker, Gökhan
Publicado: (2020)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

Letter to the editor
por: Linde, Annika, et al.
Publicado: (2016)

Letter to the editor
por: Kanna, Balavenkatesh, et al.
Publicado: (2005)

Letter to the editor
por: Rosival, Viktor
Publicado: (2005)

Letter to the editor
por: Zühlke, LJ, et al.
Publicado: (2011)

Letter to the editor
por: Naber, Kurt G
Publicado: (2011)

Letter to the Editor
por: Izumi, Reiko, et al.
Publicado: (1998)

Letter to the editor
por: D’Alessandro, Vito, et al.
Publicado: (2012)

Letter to editor
por: Reichmann, James P
Publicado: (2013)

Letter to the editor
por: Ralla, Bernhard, et al.
Publicado: (2013)

Letter to the Editor
por: Sivyer, Graham W.
Publicado: (2014)

Letter to the editor
por: Atchison, David A, et al.
Publicado: (2013)

Letter to the editor
por: Chung, Byung Ha
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7dgad8v0880f4na97lg7fcsfqb